EP. 1: Pressing Pause on Psychedelic Cash: Analysing the Challenges in Psychedelic Drug Development Through Investment TrendsByAdrienne Rivlin, Partner, L.E.K. Consulting,Jess Sharpe, Associate Consultant, L.E.K. ConsultingDecember 1st 2022